Everolimus in Anaplastic Thyroid Cancer: A Case Series

Background: Anaplastic thyroid cancer (ATC) is a very aggressive disease and accounts for over 50% of thyroid-cancer related deaths. mTOR inhibition has shown anti-tumor activity in ATC. We report our experience treating patients with ATC with everolimus off-protocol. Methods: Patients with confirme...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Oncol
Hlavní autoři: Harris, Ethan J., Hanna, Glenn J., Chau, Nicole, Rabinowits, Guilherme, Haddad, Robert, Margalit, Danielle N., Schoenfeld, Jonathan, Tishler, Roy B., Barletta, Justine A., Nehs, Matthew, Janne, Pasi, Huang, Julian, Groden, Phillip, Kacew, Alec, Lorch, Jochen
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2019
Témata:
Oncology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6399130/
https://ncbi.nlm.nih.gov/pubmed/30863722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00106
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky